Switch to:
Also traded in: Germany, Japan

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.76
TRUMY's Cash-to-Debt is ranked lower than
59% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.55 vs. TRUMY: 0.76 )
Ranked among companies with meaningful Cash-to-Debt only.
TRUMY' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.34  Med: 0.82 Max: N/A
Current: 0.76
Equity-to-Asset 0.51
TRUMY's Equity-to-Asset is ranked lower than
64% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.61 vs. TRUMY: 0.51 )
Ranked among companies with meaningful Equity-to-Asset only.
TRUMY' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.48  Med: 0.59 Max: 0.82
Current: 0.51
0.48
0.82
Interest Coverage 61.44
TRUMY's Interest Coverage is ranked higher than
53% of the 139 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 47.64 vs. TRUMY: 61.44 )
Ranked among companies with meaningful Interest Coverage only.
TRUMY' s Interest Coverage Range Over the Past 10 Years
Min: 19.91  Med: 72 Max: 1159.37
Current: 61.44
19.91
1159.37
Piotroski F-Score: 5
Altman Z-Score: 3.39
WACC vs ROIC
1.75%
8.95%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 15.19
TRUMY's Operating Margin % is ranked higher than
78% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.03 vs. TRUMY: 15.19 )
Ranked among companies with meaningful Operating Margin % only.
TRUMY' s Operating Margin % Range Over the Past 10 Years
Min: 13.23  Med: 17.08 Max: 21.85
Current: 15.19
13.23
21.85
Net Margin % 7.75
TRUMY's Net Margin % is ranked higher than
62% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.21 vs. TRUMY: 7.75 )
Ranked among companies with meaningful Net Margin % only.
TRUMY' s Net Margin % Range Over the Past 10 Years
Min: 6.26  Med: 10.78 Max: 14.16
Current: 7.75
6.26
14.16
ROE % 7.51
TRUMY's ROE % is ranked higher than
55% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.23 vs. TRUMY: 7.51 )
Ranked among companies with meaningful ROE % only.
TRUMY' s ROE % Range Over the Past 10 Years
Min: 7.03  Med: 10.91 Max: 15.01
Current: 7.51
7.03
15.01
ROA % 4.15
TRUMY's ROA % is ranked higher than
55% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. TRUMY: 4.15 )
Ranked among companies with meaningful ROA % only.
TRUMY' s ROA % Range Over the Past 10 Years
Min: 4.15  Med: 7.04 Max: 11.15
Current: 4.15
4.15
11.15
ROC (Joel Greenblatt) % 19.14
TRUMY's ROC (Joel Greenblatt) % is ranked higher than
63% of the 195 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 12.30 vs. TRUMY: 19.14 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
TRUMY' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 19.14  Med: 28.02 Max: 38.51
Current: 19.14
19.14
38.51
3-Year Revenue Growth Rate 7.30
TRUMY's 3-Year Revenue Growth Rate is ranked higher than
59% of the 159 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. TRUMY: 7.30 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
TRUMY' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: 8.4 Max: 12.5
Current: 7.3
0
12.5
3-Year EBITDA Growth Rate 10.60
TRUMY's 3-Year EBITDA Growth Rate is ranked higher than
66% of the 133 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.80 vs. TRUMY: 10.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
TRUMY' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 7.4 Max: 17.8
Current: 10.6
0
17.8
3-Year EPS without NRI Growth Rate 0.70
TRUMY's 3-Year EPS without NRI Growth Rate is ranked lower than
51% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.20 vs. TRUMY: 0.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
TRUMY' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 4.9 Max: 24.9
Current: 0.7
0
24.9
GuruFocus has detected 5 Warning Signs with Terumo Corp $TRUMY.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» TRUMY's 30-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339113 
Compare:NAS:XRAY, NYSE:WAT, NYSE:MTD, NAS:HOLX, OTCPK:OCPNY, NYSE:COO, NYSE:RMD, OTCPK:CLPBY, OTCPK:SAUHY, NYSE:WST, NYSE:STE, NYSE:BCR, NYSE:HRC, OTCPK:GNGBF, NAS:ICUI, NYSE:CMD, NAS:PODD, OTCPK:ANSLF, NAS:ILMN, NYSE:HAE » details
Traded in other countries:TUO.Germany, 4543.Japan,
Headquarter Location:Japan
Terumo Corp is a manufacturer and supplier of pharmaceuticals and medical tools and equipment. Its products include health foods, transfusion and infusion equipment, disposable medical supply, clinical testing systems & artificial organs.

Terumo Corp was incorporated in Japan on September 17, 1921. The Company is engaged in manufacturing and selling of medical products and equipment, including pharmaceuticals, nutritional food supplement, blood bags, disposable medical devices, cardiovascular systems, vascular grafts, peritoneal dialysis, blood glucose monitoring system, medical electronic, and digital thermometers. The Company operates in business segments including Cardiac & Vascular Business, Blood Management Business, and General Hospital Business. The Cardiac & Vascular Business offers products for vascular interventional treatment including interventional systems for treatment of coronary artery disease & cardiovascular systems for cardiac surgery. The Blood Management Business provides processing management system, including blood bags, leukocyte reduction filters and other equipment's. The General Hospital Business provides products that are used in hospitals on a daily basis include syringes and IV solution products, as well as products that are used by patients at home. The Company geographical segment includes Japan, Europe, Americas, Asia and others.

Top Ranked Articles about Terumo Corp

Terumo Cardiovascular Group Announces New President and CEO, Robert DeRyke
Abbott Closes St. Jude Medical Deal Wednesday The purchase will add to company's EPS in 2017
Abbott Labs (NYSE:ABT) communicated through the PRNewswire on Dec. 30 that the closure of the purchase of St. Jude Medical (NYSE:STJ) for $25 billion is expected on Wednesday. Read more...
Abbott Labs to Buy St. Jude Medical for $25 Billion Company agreed on US FTC conditions for the closing of the deal
Abbott Labs (NYSE:ABT) agreed Dec. 27 to the conditions imposed by the U.S. Federal Trade Commission for the closing of the deal that will see Abbott purchase St. Jude Medical (NYSE:STJ) for a total consideration of $25 billion. Read more...
Abbott, St. Jude Medical: Agreement Reached in Sale of Vascular Closure Products toTerumo Sale agreement reached with Terumo Corp
Abbott Laboratories (NYSE:ABT) and St. Jude Medical Inc. (NYSE:STJ) agreed to sell St. Jude Medical's Angio-Seal and Femoseal, vascular closure products, and Abbott's Vado Steerable Sheath, a heart catheter, to Terumo Corp (TSE:4543) for a consideration of approximately $1.12 billion. Read more...
Hennessy Japan Fund Trims 14 Holdings Guru reduces positions in auto companies Isuzu, Toyota
The Hennessy Japan Fund (Trades, Portfolio)’s activity in the quarter ended July 31 focused exclusively on trimming holdings in its portfolio. All 14 of its transactions in the quarter were reductions to existing stakes. Read more...

Ratios

vs
industry
vs
history
PE Ratio 45.27
TRUMY's PE Ratio is ranked lower than
76% of the 126 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.49 vs. TRUMY: 45.27 )
Ranked among companies with meaningful PE Ratio only.
TRUMY' s PE Ratio Range Over the Past 10 Years
Min: 13.9  Med: 26.4 Max: 45.27
Current: 45.27
13.9
45.27
PE Ratio without NRI 45.27
TRUMY's PE Ratio without NRI is ranked lower than
75% of the 125 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.49 vs. TRUMY: 45.27 )
Ranked among companies with meaningful PE Ratio without NRI only.
TRUMY' s PE Ratio without NRI Range Over the Past 10 Years
Min: 13.9  Med: 26.4 Max: 45.27
Current: 45.27
13.9
45.27
Price-to-Owner-Earnings 72.74
TRUMY's Price-to-Owner-Earnings is ranked lower than
80% of the 84 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 33.25 vs. TRUMY: 72.74 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
TRUMY' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 20.53  Med: 57.01 Max: 347.6
Current: 72.74
20.53
347.6
PB Ratio 3.05
TRUMY's PB Ratio is ranked higher than
54% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.28 vs. TRUMY: 3.05 )
Ranked among companies with meaningful PB Ratio only.
TRUMY' s PB Ratio Range Over the Past 10 Years
Min: 1.52  Med: 2.32 Max: 3.58
Current: 3.05
1.52
3.58
PS Ratio 3.52
TRUMY's PS Ratio is ranked lower than
53% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.25 vs. TRUMY: 3.52 )
Ranked among companies with meaningful PS Ratio only.
TRUMY' s PS Ratio Range Over the Past 10 Years
Min: 1.38  Med: 2.57 Max: 14.78
Current: 3.52
1.38
14.78
EV-to-EBIT 30.13
TRUMY's EV-to-EBIT is ranked lower than
65% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.50 vs. TRUMY: 30.13 )
Ranked among companies with meaningful EV-to-EBIT only.
TRUMY' s EV-to-EBIT Range Over the Past 10 Years
Min: 11.7  Med: 17.5 Max: 84.4
Current: 30.13
11.7
84.4
EV-to-EBITDA 30.13
TRUMY's EV-to-EBITDA is ranked lower than
80% of the 135 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 18.46 vs. TRUMY: 30.13 )
Ranked among companies with meaningful EV-to-EBITDA only.
TRUMY' s EV-to-EBITDA Range Over the Past 10 Years
Min: 8.8  Med: 16.9 Max: 84.4
Current: 30.13
8.8
84.4
PEG Ratio 4.58
TRUMY's PEG Ratio is ranked lower than
67% of the 66 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.81 vs. TRUMY: 4.58 )
Ranked among companies with meaningful PEG Ratio only.
TRUMY' s PEG Ratio Range Over the Past 10 Years
Min: 2.49  Med: 5.85 Max: 42.34
Current: 4.58
2.49
42.34
Shiller PE Ratio 76.20
TRUMY's Shiller PE Ratio is ranked lower than
82% of the 49 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 50.38 vs. TRUMY: 76.20 )
Ranked among companies with meaningful Shiller PE Ratio only.
TRUMY' s Shiller PE Ratio Range Over the Past 10 Years
Min: 64.87  Med: 68.56 Max: 76.2
Current: 76.2
64.87
76.2
Current Ratio 1.94
TRUMY's Current Ratio is ranked lower than
64% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. TRUMY: 1.94 )
Ranked among companies with meaningful Current Ratio only.
TRUMY' s Current Ratio Range Over the Past 10 Years
Min: 0.83  Med: 2.35 Max: 4.1
Current: 1.94
0.83
4.1
Quick Ratio 1.54
TRUMY's Quick Ratio is ranked lower than
57% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.73 vs. TRUMY: 1.54 )
Ranked among companies with meaningful Quick Ratio only.
TRUMY' s Quick Ratio Range Over the Past 10 Years
Min: 0.61  Med: 1.75 Max: 3.14
Current: 1.54
0.61
3.14
Days Inventory 157.17
TRUMY's Days Inventory is ranked lower than
66% of the 183 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 128.19 vs. TRUMY: 157.17 )
Ranked among companies with meaningful Days Inventory only.
TRUMY' s Days Inventory Range Over the Past 10 Years
Min: 124.64  Med: 132.21 Max: 157.17
Current: 157.17
124.64
157.17
Days Payable 9.65
TRUMY's Days Payable is ranked lower than
98% of the 152 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 50.69 vs. TRUMY: 9.65 )
Ranked among companies with meaningful Days Payable only.
TRUMY' s Days Payable Range Over the Past 10 Years
Min: 8.29  Med: 82.1 Max: 86.88
Current: 9.65
8.29
86.88

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.43
TRUMY's Dividend Yield % is ranked lower than
56% of the 158 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.17 vs. TRUMY: 0.43 )
Ranked among companies with meaningful Dividend Yield % only.
TRUMY' s Dividend Yield % Range Over the Past 10 Years
Min: 0.43  Med: 0.93 Max: 1.46
Current: 0.43
0.43
1.46
Dividend Payout Ratio 0.40
TRUMY's Dividend Payout Ratio is ranked lower than
62% of the 92 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.30 vs. TRUMY: 0.40 )
Ranked among companies with meaningful Dividend Payout Ratio only.
TRUMY' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.15  Med: 0.18 Max: 0.4
Current: 0.4
0.15
0.4
3-Year Dividend Growth Rate 20.00
TRUMY's 3-Year Dividend Growth Rate is ranked higher than
73% of the 64 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.40 vs. TRUMY: 20.00 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
TRUMY' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 17 Max: 33
Current: 20
0
33
Forward Dividend Yield % 0.85
TRUMY's Forward Dividend Yield % is ranked lower than
66% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.27 vs. TRUMY: 0.85 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 1.00
TRUMY's 5-Year Yield-on-Cost % is ranked higher than
62% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.44 vs. TRUMY: 1.00 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
TRUMY' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1  Med: 2.17 Max: 3.41
Current: 1
1
3.41
3-Year Average Share Buyback Ratio 1.50
TRUMY's 3-Year Average Share Buyback Ratio is ranked higher than
92% of the 131 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -4.20 vs. TRUMY: 1.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
TRUMY' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -1.3  Med: 0.7 Max: 0
Current: 1.5
-1.3
0

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 7.81
TRUMY's Price-to-Tangible-Book is ranked lower than
70% of the 158 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.75 vs. TRUMY: 7.81 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
TRUMY' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.7  Med: 5.03 Max: 9.22
Current: 7.81
2.7
9.22
Price-to-Intrinsic-Value-Projected-FCF 3.84
TRUMY's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
73% of the 86 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.24 vs. TRUMY: 3.84 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
TRUMY' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.53  Med: 1.94 Max: 3.99
Current: 3.84
1.53
3.99
Price-to-Intrinsic-Value-DCF (Earnings Based) 4.23
TRUMY's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
91% of the 22 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.12 vs. TRUMY: 4.23 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.37
TRUMY's Price-to-Median-PS-Value is ranked lower than
63% of the 174 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.12 vs. TRUMY: 1.37 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
TRUMY' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.62  Med: 0.99 Max: 5.19
Current: 1.37
0.62
5.19
Price-to-Peter-Lynch-Fair-Value 6.14
TRUMY's Price-to-Peter-Lynch-Fair-Value is ranked lower than
88% of the 49 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.46 vs. TRUMY: 6.14 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
TRUMY' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.67  Med: 2.85 Max: 6.88
Current: 6.14
0.67
6.88
Price-to-Graham-Number 3.97
TRUMY's Price-to-Graham-Number is ranked lower than
73% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.52 vs. TRUMY: 3.97 )
Ranked among companies with meaningful Price-to-Graham-Number only.
TRUMY' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.64  Med: 2.35 Max: 3.97
Current: 3.97
1.64
3.97
Earnings Yield (Greenblatt) % 3.32
TRUMY's Earnings Yield (Greenblatt) % is ranked higher than
60% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.66 vs. TRUMY: 3.32 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
TRUMY' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 1.2  Med: 5.7 Max: 8.6
Current: 3.32
1.2
8.6
Forward Rate of Return (Yacktman) % 7.37
TRUMY's Forward Rate of Return (Yacktman) % is ranked lower than
58% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.07 vs. TRUMY: 7.37 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
TRUMY' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -8  Med: -1.6 Max: 11.8
Current: 7.37
-8
11.8

More Statistics

Revenue (TTM) (Mil) $4,623.84
EPS (TTM) $ 0.92
Beta0.30
Short Percentage of Float0.00%
52-Week Range $33.90 - 46.00
Shares Outstanding (Mil)362.97 (ADR)

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}